Skeptical of ASTS's ability to scale its direct-to-cell technology despite a compelling idea.
Source Post
$RKLB Stock Goes Hypersonic, Plus $ASTS Earnings and Comparison
Buy Hold Rant - Stocks and InvestingMay 14, 2026
The creator discusses selling a portion of their Rocket Lab ($RKLB) holdings, despite believing it's a fantastic company with strong execution and a positive outlook. They explain that the stock's high valuation (110x revenue) makes it overvalued, prompting them to trim their position as it rises, adhering to a buy low, sell high strategy. Another participant also discusses trimming their RKLB position after achieving a significant return.
Linked Mentions
Tickers discussed in this post
Creator is selling portions of RKLB due to its high valuation, despite believing it's a great company.
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.